Elkhart, IN, United States of America

Robert C Bocuslaski

This inventor holds 1 USPTO granted patent. Top assignee: Miles Laboratories, Inc.. Active years: 1982.


% Patents Active = 100.0

Average Co-Inventor Count = 3.0

ph-index = 1

Forward Citations = 32(Granted Patents)


Company Filing History:


Years Active: 1982

Loading Chart...
1 patent (USPTO):Explore Patents

Title: The Innovations of Robert C. Bocuslaski

Introduction

Robert C. Bocuslaski is a notable inventor based in Elkhart, Indiana. He holds a patent that contributes significantly to the field of biochemical assays. His expertise in developing improved methods and reagents highlights his innovation-driven career.

Latest Patents

Bocuslaski is the inventor behind a unique patent titled ".beta.-Galactosyl-umbelliferone-labeled protein and polypeptide." This patent presents an advanced specific binding assay method and reagent designed for detecting a ligand in a liquid medium. The invention employs an enzyme-cleavable substrate label, showcasing his contribution to enhancing biochemical analysis techniques.

Career Highlights

Working at Miles Laboratories, Inc., Bocuslaski has made strides in the pharmaceutical and biochemical industries. His inventive approach within the company has enabled advancements in laboratory practices and methodologies, marking him as an essential figure in his field.

Collaborations

Throughout his career, Bocuslaski has collaborated with esteemed colleagues such as John F. Burd and Robert J. Carrico. These partnerships have fostered innovation within the research community, resulting in valuable contributions to science and technology.

Conclusion

Robert C. Bocuslaski exemplifies the spirit of innovation. His patent and collaborative efforts at Miles Laboratories, Inc. signify a commitment to advancing scientific inquiry and practical applications. As a dedicated inventor, Bocuslaski's work continues to influence the field of biochemical assays.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to [email protected]
Loading…